SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AMLN (DIABETES DRUGS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2173 62 0 AMLN
Emcee:  eric siegel Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2048The market may welcome the news, but ML is not terribly impressed: Byetta labeltom pope-12/22/2006
2047I see the stock has tacked 3% or so on after hours. Nothing seemed to be happentuck-12/22/2006
2046>>FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Ustuck-12/22/2006
2045Merrill: Lowering Byetta estimates on NDC data Amylin and Lilly expect Byetta stom pope-12/18/2006
2044Smith Barney market estimates for GLP-1 and DPP-IV drugs: investorvillage.com tuck-12/13/2006
2043does anyone here know of a series 2 diabetes natural supplement from a company wlongtermholdings-12/11/2006
2042What's interesting is byetta is doing far better than people expected. I donrkrw-12/7/2006
2041AMLN's downtrend continues with no direct news, however I'm hearing thattuck-12/7/2006
2040sermo.com contains some astonishing accusations about side effects from Lipitor DewDiligence_on_SI-10/14/2006
2039Merrill: Encouraging top-line data for Symlin in earlier usage setting Amylin rtom pope-9/8/2006
2038Presents their breakthrough today. I think we will see Diamyd shares climb 100%-B O Trust-8/23/2006
2037wrong place sorryB O Trust-8/23/2006
2036Lilly, Amylin Say Cartridges Supplies Adequate to Lift Diabetes-Drug RestrictionDoc Bones-8/16/2006
2035Righto. I have never liked the "gauge" measurement; it's an ancierareearth42-7/26/2006
2034Yes, a larger needle, smaller needle gauge. I inserted the note in square brackeDewDiligence_on_SI-7/25/2006
2033Dew, Regarding <i>It sounds like LAR has pushed the limits of Medisorb (rareearth42-7/25/2006
2032Hello Praveen, I've commented at length about Conjuchem on the Yahoo AMLN brareearth42-7/25/2006
2031Canada has let the way in diabetes treatment, for sure, bless 'em. The arickeokalani'nui-7/25/2006
2030Canadian companies striving to lead in diabetes research Canadian Press VANCOUdr.praveen-7/24/2006
2029cjc.to is radioactive in my opinion and I got roasted because of it. If you guykeokalani'nui-7/24/2006
2028"Competitively lar is still their most important project and they can'tdr.praveen-7/23/2006
2027I wouldn't really know but I don't imagine it would be that easy. And ifrkrw-7/23/2006
2026Altus is working with a 30 gauge which I find very impressive given they're rkrw-7/23/2006
2025Merrill, couple of days ago: Strong Byetta 2Q sales of $99 mn, despite supply ctom pope-7/22/2006
2024This is a good analysis of the LAR situation, IMO: www1.investorvillage.com &lDewDiligence_on_SI-7/22/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News